May 15, 2024
Sojitz Corporation
Ginkgo Bioworks, Inc.

Sojitz Corporation and Ginkgo Bioworks Announce Plans to Use Synthetic Biology R&DServices to Accelerate Sustainable Manufacturing in Japan- Sojitz intends to use its extensive network to help Ginkgo foster business connections
within the Japanese bioeconomy-

Sojitz Corporation, a Japanese general trading company with extensive networks within the Japanesebioeconomy, and Ginkgo Bioworks (NYSE: DNA), which is building the leading platform for cell
programming and biosecurity, today announced that they have entered into a binding definitiveagreement. Together, Sojitz and Ginkgo aim to build connections with key Japanese businesses andencourage the use of synthetic biology to develop sustainable production processes.

Sojitz Corporation and Ginkgo will collaborate in a joint business development effort to offer Ginkgo's
R&D services to Japanese customers. Sojitz believes Ginkgo's unique synthetic biology research anddevelopment services will appeal to customers within the Japanese bioeconomy that are looking toreplace petroleum and chemical-based manufacturing processes with bio-based ones.

The Japanese government has formulated a Bioeconomy Strategy that envisions a $837 billion (USD)
bioeconomy, and is looking to develop biotechnology applications across industries as it pursues its
climate commitments to reach net zero by 2050. Ginkgo hopes to apply its platform in support of theJapanese biotech ecosystem to accelerate progress to achieving this vision.

[Ginkgo’s R&D facility for cell programming]

Koji Izutani, Managing Executive Officer, Sojitz:"We are pleased to introduce Ginkgo's technology to Japanese companies that have a desire to reduce
their carbon footprint and develop sustainable fermentation processes. We are confident that Ginkgo's
expertise in synthetic biology and the breadth of its technology platform can be used to transform
processes across various Japanese industries, including industrial biotechnology."

Ena Cratsenburg, Chief Business Officer, Ginkgo:"We're thrilled to join efforts with Sojitz and collaborate on bolstering the Japanese bioeconomy. Sojitz
is a well respected trading company that has extensive relationships with many of the major industrial
and chemical companies in Japan. We look forward to working with Japanese companies to leverage
our synthetic biology platform to accelerate the development and launch of bio-based and sustainableproducts in Japan."

About Ginkgo Bioworks
Ginkgo Bioworks is the leading horizontal platform for cell programming, providing flexible, end-to-end
services that solve challenges for organizations across diverse markets, from food and agriculture topharmaceuticals to industrial and specialty chemicals. Ginkgo Biosecurity is building and deploying thenext-generation infrastructure and technologies that global leaders need to predict, detect, and respondto a wide variety of biological threats.
GINKGO BIOWORKS MEDIA CONTACT:press@ginkgobioworks.com

About Sojitz Corporation
Sojitz Corporation was formed out of the union of Nichimen Corporation and Nissho Iwai Corporation,
both companies that boast incredibly long histories. For more than 160 years, our business has helped
support the development of countless countries and regions. Today, the Sojitz Group consists ofapproximately 400 subsidiaries and affiliates located in Japan and throughout the world, developing
wide-ranging general trading company operations in a multitude of countries and regions.

Contact: Sojitz Corporation

双日株式会社 広報部

Public Relations Dept.

東京都千代田区内幸町 2-1-1+81-3-6871-3404

TEL:03-6871-3404

hodo@sojitz.com